Burjis Godrej takes charge as MD of Astec LifeSciences amid financial challenges

Burjis Godrej, son of Nadir Godrej, chairman of Godrej Industries Group (GIG), has taken charge as the managing director of Astec LifeSciences, marking his first major leadership and accountability role within the organization. Burjis assumes his new role this month at the listed entity without any remuneration, taking over from Anurag Roy, who resigned as CEO of Astec in October 2024. At 34, Burjis is the elder son of Nadir Godrej, while his younger brother, Hormazd, has also recently joined Godrej Agrovet. Nadir Godrej is the younger brother of GIG chairman emeritus, Adi Godrej.

«Getting the opportunity to make an impact in a sector that is a key focus area of the group and is important for growing India’s R&D and manufacturing footprint was more important to me personally than the remuneration. I look forward to working closely with the Astec team to drive growth in this business,» Burjis Godrej told ET. He also served as a non-executive director at Astec LifeSciences

Since 2022, Burjis Godrej has held the position of Executive Director at GAVL. He was previously a Non-Executive Director at Astec LifeSciences and Godrej Maxximilk. Burjis has specialized in agrochemical projects for Astec LifeSciences and the crop protection division of Godrej Agrovet. His responsibilities included evaluation of products, synergies, technologies, business models, geographical markets, and capital expenditure

With persistent challenges in growth and financial health, investor sentiment remains weak in Astec LifeSciences. Burjis